Petros Pharmaceuticals, Inc. (CIK 1815903, PTPI) reported a bankruptcy or receivership to the SEC on Form 8-K under Item 1.03, the latest filed 2026-09-30. It gives its business address as New York, New York. Its registered industry is Pharmaceutical Preparations. The sentences below are quoted from the filings as written.
The filings
Form 8-K filed 2026-09-30 · Receivership or assignment
Chapter
On September 30, 2026, Petros Pharmaceuticals, Inc. (the "Company") entered into a General Assignment for the Benefit of Creditors (the "Assignment"), pursuant to California law, in which it assigned all of its right, title, and interest in its assets to PT Liquidation, LLC, as Assignee, for the benefit of the Company's creditors (the "ABC").
Where this comes from
Public companies report a bankruptcy, a receivership or a similar proceeding to the SEC on Form 8-K under Item 1.03, usually within four business days. Every filing listed here is one of them, linked to the filing itself. The sentences shown are quoted from the filing exactly; where a filing does not state the court, the case or the chapter in one sentence, nothing is shown in its place.
The state is where the company says its business is, and the industry is the one it registered with the SEC. A filing reports what the company filed; it does not say whether creditors will be paid, and neither does this page.
All recent bankruptcy filingsThat week
Who owns Petros Pharmaceuticals, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/bankruptcy/petros-pharmaceuticals